Geneos Wealth Management’s Enterprise Products Partners EPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Buy
55,340
+495
+0.9% +$17.5K 0.05% 346
2025
Q4
$1.76M Buy
54,845
+2,727
+5% +$86.2K 0.04% 379
2025
Q3
$1.63M Buy
52,118
+3,770
+8% +$119K 0.04% 384
2025
Q2
$1.5M Sell
48,348
-18,166
-27% -$566K 0.04% 435
2025
Q1
$2.27M Buy
66,514
+40,849
+159% +$1.36M 0.03% 459
2024
Q4
$805K Buy
25,665
+512
+2% +$15.7K 0.03% 473
2024
Q3
$732K Sell
25,153
-2,163
-8% -$63.2K 0.03% 470
2024
Q2
$792K Buy
27,316
+5,544
+25% +$159K 0.04% 398
2024
Q1
$635K Sell
21,772
-47
-0.2% -$1.29K 0.03% 437
2023
Q4
$575K Sell
21,819
-7,247
-25% -$193K 0.03% 447
2023
Q3
$796K Sell
29,066
-1,751
-6% -$46.8K 0.04% 358
2023
Q2
$812K Sell
30,817
-36,863
-54% -$964K 0.04% 354
2023
Q1
$1.75M Sell
67,680
-10,474
-13% -$269K 0.11% 214
2022
Q4
$1.89M Buy
78,154
+10,679
+16% +$263K 0.11% 187
2022
Q3
$1.6M Sell
67,475
-21,334
-24% -$550K 0.11% 190
2022
Q2
$2.19M Buy
88,809
+10,802
+14% +$284K 0.11% 201
2022
Q1
$2.01M Buy
78,007
+8,295
+12% +$201K 0.09% 222
2021
Q4
$1.53M Sell
69,712
-4,816
-6% -$108K 0.06% 298
2021
Q3
$1.62M Buy
74,528
+12,398
+20% +$282K 0.06% 283
2021
Q2
$1.53M Sell
62,130
-61
-0.1% -$1.44K 0.06% 278
2021
Q1
$1.43M Sell
62,191
-6,856
-10% -$151K 0.04% 340
2020
Q4
$1.5M Sell
69,047
-2,862
-4% -$53.3K 0.06% 276
2020
Q3
$1.11M Sell
71,909
-2,728
-4% -$47.8K 0.06% 271
2020
Q2
$1.31M Buy
74,637
+610
+0.8% +$10.9K 0.07% 244
2020
Q1
$1.03M Sell
74,027
-1,297
-2% -$30.1K 0.07% 250
2019
Q4
$2.12M Buy
75,324
+2,105
+3% +$57.1K 0.11% 195
2019
Q3
$2.1M Sell
73,219
-2,405
-3% -$70K 0.13% 179
2019
Q2
$2.18M Sell
75,624
-1,720
-2% -$49.6K 0.14% 165
2019
Q1
$2.25M Buy
77,344
+139
+0.2% +$3.88K 0.15% 168
2018
Q4
$1.84M Buy
77,205
+1,774
+2% +$47.5K 0.14% 175
2018
Q3
$2.17M Buy
75,431
+4,283
+6% +$124K 0.14% 167
2018
Q2
$1.97M Sell
71,148
-11,089
-13% -$303K 0.15% 147
2018
Q1
$2.01M Sell
82,237
-1,403
-2% -$37.4K 0.18% 128
2017
Q4
$2.22M Buy
83,640
+19,722
+31% +$499K 0.2% 125
2017
Q3
$1.67M Sell
63,918
-71
-0.1% -$1.88K 0.17% 139
2017
Q2
$1.73M Sell
63,989
-3,503
-5% -$94.9K 0.18% 129
2017
Q1
$1.86M Buy
67,492
+2,999
+5% +$83.8K 0.19% 116
2016
Q4
$1.74M Buy
64,493
+4,725
+8% +$123K 0.23% 106
2016
Q3
$1.65M Sell
59,768
-2,506
-4% -$69.2K 0.22% 108
2016
Q2
$1.81M Buy
62,274
+726
+1% +$19.5K 0.26% 92
2016
Q1
$1.49M Buy
+61,548
New +$1.43M 0.23% 109

Other funds holding EPD

Geneos Wealth Management's EPD Position: Q1 2026 in Review

Geneos Wealth Management increased its Enterprise Products Partners (EPD) stake by 0.9% in Q1 2026, buying an estimated $17.5K and bringing the position to 55,340 shares worth $2.09M. The position accounts for 0.05% of the portfolio, ranked #346.

Geneos Wealth Management first reported a position in EPD in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.27M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold EPD as of Q1 2026.

  • Geneos Wealth Management held 55,340 shares of Enterprise Products Partners worth $2.09M as of Q1 2026.
  • Geneos Wealth Management bought 495 Enterprise Products Partners shares in Q1 2026, an estimated $17.5K.
  • Enterprise Products Partners made up 0.05% of Geneos Wealth Management's portfolio in Q1 2026, its #346 holding.
  • Geneos Wealth Management first reported a position in Enterprise Products Partners in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Enterprise Products Partners position peaked at $2.27M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Enterprise Products Partners as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.